Peptides having a structure characterized by the presence of two loops constrained in cyclic structure by the presence of covalent bonds between amino acid side chains, the amino acid sequences of the first and the second loop being substantially homologues to that of loop 1 (residues 29-38) and of loop 4 (residues 92 - 97) of NGF, respectively, displaying nerve growth factor (NGF) agonist or partial agonist activity.

HETERODIMERIC PEPTIDE COMPOUNDS DISPLAYING NGF ACTIVITY AND THEIR USE TO TREAT NEURODEGENERATIVE DISORDERS / Morelli, Giancarlo; L., Vitagliano; L., Zaccaro; E., Martegani. - (2005).

HETERODIMERIC PEPTIDE COMPOUNDS DISPLAYING NGF ACTIVITY AND THEIR USE TO TREAT NEURODEGENERATIVE DISORDERS

MORELLI, GIANCARLO;
2005

Abstract

Peptides having a structure characterized by the presence of two loops constrained in cyclic structure by the presence of covalent bonds between amino acid side chains, the amino acid sequences of the first and the second loop being substantially homologues to that of loop 1 (residues 29-38) and of loop 4 (residues 92 - 97) of NGF, respectively, displaying nerve growth factor (NGF) agonist or partial agonist activity.
2005
HETERODIMERIC PEPTIDE COMPOUNDS DISPLAYING NGF ACTIVITY AND THEIR USE TO TREAT NEURODEGENERATIVE DISORDERS / Morelli, Giancarlo; L., Vitagliano; L., Zaccaro; E., Martegani. - (2005).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/10816
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact